NASDAQ · NRIX
Nurix Therapeutics, Inc.
Healthcare · Biotechnology
$15.48
Down-$0.12 (-0.77%)
Updated Nov 15, 2026, 12:04 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.47B
- P/E ratio
- -6.56
- Dividend yield
- 0.00%
- 52-week range
- $12.01 – $28.23
- Volume
- 1.39M
- Avg. volume
- 1.68M
Price performance · NRIX
NRIX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
NRIX closed at $15.48 after 20 trading sessions, down 37.91% for the selected period.
- Last close
- $15.48
- Period change
- -37.91%
- Period low
- $14.84
- Period high
- $27.26
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $15.50 | $15.76 | $15.19 | $15.48 | 1.39M |
| Nov 12, 2026 | $16.39 | $16.55 | $15.545 | $15.60 | 1.34M |
| Nov 11, 2026 | $16.00 | $16.70 | $15.915 | $16.33 | 2.98M |
| Nov 10, 2026 | $16.00 | $16.76 | $15.75 | $15.88 | 3.05M |
| Nov 9, 2026 | $15.32 | $16.63 | $15.265 | $16.14 | 7.6M |
| Nov 6, 2026 | $15.10 | $15.52 | $14.791 | $15.30 | 2.98M |
| Nov 5, 2026 | $16.01 | $16.5939 | $14.80 | $14.84 | 7.09M |
| Nov 4, 2026 | $17.16 | $17.28 | $14.78 | $15.95 | 19.56M |
| Nov 3, 2026 | $25.72 | $26.55 | $25.6325 | $25.82 | 4.39M |
| Nov 2, 2026 | $26.75 | $26.9569 | $25.532 | $25.70 | 2.35M |
| Oct 30, 2026 | $26.90 | $26.915 | $25.97 | $26.80 | 2.31M |
| Oct 29, 2026 | $27.46 | $27.99 | $26.685 | $27.12 | 2.38M |
| Oct 28, 2026 | $26.26 | $27.28 | $25.45 | $27.26 | 1.96M |
| Oct 27, 2026 | $25.52 | $27.05 | $25.13 | $26.70 | 2.56M |
| Oct 26, 2026 | $25.35 | $25.82 | $25.03 | $25.55 | 2.34M |
| Oct 23, 2026 | $25.22 | $25.49 | $24.775 | $25.34 | 1.91M |
| Oct 22, 2026 | $25.86 | $26.225 | $25.1801 | $25.51 | 1.93M |
| Oct 21, 2026 | $26.00 | $26.31 | $25.80 | $26.02 | 2.93M |
| Oct 20, 2026 | $24.92 | $26.34 | $24.71 | $26.10 | 3.98M |
| Oct 19, 2026 | $24.57 | $25.29 | $24.3837 | $24.93 | 3.06M |
Latest NRIX news
The latest Smart Investors Daily articles mentioning NRIX.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

